Myosin 9 (MYH9) (Middle Region) Peptide
-
- Target See all Myosin 9 (MYH9) products
- Myosin 9 (MYH9)
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-MYH9 antibody (Catalog #: ARP48072_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Myosin 9 (MYH9)
- Background
-
MYH9 is a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain. The protein is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in MYH9 are the cause of non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness.
Alias Symbols: DFNA17, EPSTS, FTNS, MGC104539, MHA, NMHC-II-A, NMMHCA, BDPLT6, NMMHC-IIA
Protein Interaction Partner: ASCC2,CD163,CXCR4,GRIN1,MEN1,MYBPC3,MYH10,MYL9,MYOM1,MYOM2,OVGP1,PTPN6,S100A4,TTN,TUFM,ASCC2,EPB41,MARK4,MYL9,PRKCE,USP1,USP45
Protein Size: 1960 - Molecular Weight
- 226 kDa
- Gene ID
- 4627
- NCBI Accession
- NM_002473, NP_002464
- UniProt
- P35579
-